|
Brian Greenwood Keynote speaker MIM 2018 |
After qualifying in medicine at Cambridge University, Brian Greenwood spent 15 years working in Nigeria, first at University College Hospital, Ibadan and then at Ahmadu Bello University, Zaria where he helped to start a new medical school and where he developed his research interests in malaria and meningitis. In 1980, he moved to The Gambia where he spent the next 15 years as director of the UK’s Medical Research Council Laboratories, focusing his research on the prevention of the major infectious diseases prevalent in West African children including malaria, pneumonia and meningitis.
In 1996, he moved to the London School of Hygiene & Tropical Medicine where he has maintained his research on the prevention of malaria, meningococcal and pneumococcal infections in Africa, including trials that led to the development of Seasonal Malaria Chemoprevention, and he is currently supporting a trial of the use RTS,S/AS01 as a seasonal malaria vaccine, continuing his 20 year involvement in the development and evaluation of this vaccine. He is also supporting an evaluation of an Ebola vaccine in Sierra Leone.
From 2000 – 2008, he coordinated the Gates Malaria Partnership, a programme of malaria research and capacity development in several countries in Africa and, from 2008 – 2017, he coordinated a successor malaria research capacity development initiative, the Malaria Capacity Development Consortium (MCDC). MCDC has been followed by a new research capacity development programme (MARCAD) led by the University of Dakar, Senegal which he supports.